Biblio
Export 1092 results:
Author [ Title
Filters: First Letter Of Keyword is C [Clear All Filters]
“PDE5 Exists in Human Neurons and is a Viable Therapeutic Target for Neurologic Disease.”, J Alzheimers Dis, vol. 52, no. 1, pp. 295-302, 2016.
, “Peptidylarginine Deiminase and Alzheimer's Disease.”, J Alzheimers Dis, vol. 85, no. 2, pp. 473-484, 2022.
, “Peptidylarginine Deiminase and Alzheimer's Disease.”, J Alzheimers Dis, vol. 85, no. 2, pp. 473-484, 2022.
, “Performance of Hippocampus Volumetry with FSL-FIRST for Prediction of Alzheimer's Disease Dementia in at Risk Subjects with Amnestic Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 51, no. 3, pp. 867-73, 2016.
, “Performance on Specific Cognitive Domains and Cause of Death: A Prospective Population-Based Study in Non-Demented Older Adults (NEDICES).”, J Alzheimers Dis, vol. 51, no. 2, pp. 533-44, 2016.
, “Performance on Specific Cognitive Domains and Cause of Death: A Prospective Population-Based Study in Non-Demented Older Adults (NEDICES).”, J Alzheimers Dis, vol. 51, no. 2, pp. 533-44, 2016.
, “Performance on Specific Cognitive Domains and Cause of Death: A Prospective Population-Based Study in Non-Demented Older Adults (NEDICES).”, J Alzheimers Dis, vol. 51, no. 2, pp. 533-44, 2016.
, “Perspectives on Communicating Biomarker-Based Assessments of Alzheimer's Disease to Cognitively Healthy Individuals.”, J Alzheimers Dis, vol. 62, no. 2, pp. 487-498, 2018.
, “Phase 3 trials of solanezumab for mild-to-moderate Alzheimer's disease.”, N Engl J Med, vol. 370, no. 4, pp. 311-21, 2014.
, “Physical Activity and Hippocampal Sub-Region Structure in Older Adults with Memory Complaints.”, J Alzheimers Dis, vol. 61, no. 3, pp. 1089-1096, 2018.
, “Physical Activity and Hippocampal Sub-Region Structure in Older Adults with Memory Complaints.”, J Alzheimers Dis, vol. 61, no. 3, pp. 1089-1096, 2018.
, “The PI3K/AKT Signaling Pathway and Caspase-3 in Alzheimer's Disease: Which One Is the Beginner?”, J Alzheimers Dis, vol. 92, no. 2, pp. 391-393, 2023.
, “Plasma BDNF/Irisin Ratio Associates with Cognitive Function in Older People.”, J Alzheimers Dis, vol. 99, no. 4, pp. 1261-1271, 2024.
, “Plasma BDNF/Irisin Ratio Associates with Cognitive Function in Older People.”, J Alzheimers Dis, vol. 99, no. 4, pp. 1261-1271, 2024.
, “Plasma BDNF/Irisin Ratio Associates with Cognitive Function in Older People.”, J Alzheimers Dis, vol. 99, no. 4, pp. 1261-1271, 2024.
, “Plasma BDNF/Irisin Ratio Associates with Cognitive Function in Older People.”, J Alzheimers Dis, vol. 99, no. 4, pp. 1261-1271, 2024.
, “Plasma Biomarkers of Alzheimer's Disease in African Americans.”, J Alzheimers Dis, vol. 79, no. 1, pp. 323-334, 2021.
, “Plasma Glial Fibrillary Acidic Protein Is Associated with 18F-SMBT-1 PET: Two Putative Astrocyte Reactivity Biomarkers for Alzheimer's Disease.”, J Alzheimers Dis, vol. 92, no. 2, pp. 615-628, 2023.
, “Plasma phospholipids identify antecedent memory impairment in older adults.”, Nat Med, vol. 20, no. 4, pp. 415-8, 2014.
, “Plasma phospholipids identify antecedent memory impairment in older adults.”, Nat Med, vol. 20, no. 4, pp. 415-8, 2014.
, “Plasma Soluble ST2 Levels Are Higher in Neurodegenerative Disorders and Associated with Poorer Cognition.”, J Alzheimers Dis, vol. 92, no. 2, pp. 573-580, 2023.
, “Plasma Soluble ST2 Levels Are Higher in Neurodegenerative Disorders and Associated with Poorer Cognition.”, J Alzheimers Dis, vol. 92, no. 2, pp. 573-580, 2023.
, “Platelet Membrane β-Secretase Activity in Mild Cognitive Impairment and Conversion to Dementia: a Longitudinal Study.”, J Alzheimers Dis, vol. 49, no. 4, pp. 1095-103, 2016.
, “Platelet Membrane β-Secretase Activity in Mild Cognitive Impairment and Conversion to Dementia: a Longitudinal Study.”, J Alzheimers Dis, vol. 49, no. 4, pp. 1095-103, 2016.
, “Platelet Membrane β-Secretase Activity in Mild Cognitive Impairment and Conversion to Dementia: a Longitudinal Study.”, J Alzheimers Dis, vol. 49, no. 4, pp. 1095-103, 2016.
,